1Beriou G, Moreau A, Cuturi MC. Tolerogenic dendritic cells: applications for solid organ transplantation[J]. Curr Opin Organ Transplant, 2012, 17(1): 42-47. 被引量：1
2Zheng DH, Dou LP, Wei YX, et al. Uptake of donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light by recipient dendritic cells induces CD4+CD25+Foxp3+ regulatory T cells and down-regulates cardiac allograft rejection[J]. Biochem Biophys Res Commun, 2010, 395 (4): 540-546. 被引量：1
3Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J].J Exp Med, 1992, 176(6): 1693-1702. 被引量：1
4Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CDldhiCD5+ phenotype controls T cell- dependent inflammatory responses[J]. Immunity, 2008, 28(5): 639-650. 被引量：1
5Wojciechowski W, Harris DP, Sprague F, et al. Cytokine- producing effector B cells regulate type 2 immunity to H. polygyrus[J]. Immunity, 2009, 30(3): 421-433. 被引量：1
6Mizoguchi A, Bhan AK. A case for regulatory B cells[J]. JImmunol, 2006, 176(2): 705-710. 被引量：1
7Evans JG, Chavez-Rueda KA, Eddaoudi A. Novel suppressive function of transitional 2 B cells in experimental arthritis[J]. J Immunol, 2007, 178(12): 7868-7878. 被引量：1
8Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-1ike B cells and for the suppression of lupus in MRL/lpr mice[J]. J Immunol, 2009, 182(6): 3492-3502. 被引量：1
9Watanabe R, Ishiura N, Nakashima H, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity[J]. J Immunol, 2010, 184(9): 4801-4809. 被引量：1
10Fillatreau S,Gray D,Anderton SM.Not always the bad guys:B cellsas regulators of autoimmune pathology[J].Nat Rev Immunol,2008,5; 391-397. 被引量：1
3Pravica V, Popadic D, Savic E, et al. Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers[J]. Immunol Res, 2012, 52 (1/2) :42-52. 被引量：1
4Cheng Q, Cheng XJ, Jiang GX. Multiple sclerosis in China-- history and future[J].Mult Scler, 2009, 15(6) :655-660. 被引量：1
5Das UN. Is multiple sclerosis a proresolution deficiency disorder? [J]. Nutrition, 2012, 28(10):951-958. 被引量：1
6Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease[J]. Crit Rev Immunol, 2012, 32(1) :23-63. 被引量：1
7de Jong BA, Westendorp RG, Eskdale J, et al. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis[J]. Hum Immunol, 2002, 63(4):281-285. 被引量：1
8Forte GI, Ragonese P, Salemi G, et al. Search for genetic factors associated with susceptibility to multiple sclerosis[J]: Ann N Y Acad Sci, 2006, 1067:264-269. 被引量：1
9Izad M, Vodjgani M, Niknam MH, et al. Cytokines genes polymorphisms and risk of multiple sclerosis[J]. Am J Med Sci, 2010, 339(4) :327-331. 被引量：1
10M/iurer M, Kruse N, Giess R, et al. Genetic variation at position --1082 of the interleukin 10 (ILl0) promotor and the outcome of multiple sclerosis[J].J Neuroimmunol, 2000, 104 (1) :98-100. 被引量：1
